Secondary analysis of ARCADIA (1,015 patients with cryptogenic stroke and atrial cardiopathy): apixaban caused fewer intracranial haemorrhages than aspirin (annualised difference -1.4%), with no significant difference in major non-intracranial, any major or minor bleeding.
Secondary analysisn = 1,015
Kamel et al. Apixaban Versus Aspirin and Risk of Hemorrhage in the ARCADIA Trial